您的位置: 首页 > 农业专利 > 详情页

ZYTOTOXISCHER MONOKLONALER ANTIKÖRPER GEGEN KREBS
专利权人:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人:
YOUNG, DAVID, S., F.,FINDLAY, HELEN, P.,HAHN, SUSAN, E.,POPP, LISA, A.
申请号:
EP09749358
公开号:
EP2291406A4
申请日:
2009.05.15
申请国别(地区):
EP
年份:
2012
代理人:
摘要:
The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充